| Description | Satralizumab, a humanized monoclonal antibody and potent Interleukin-6 (IL-6) inhibitor, prevents the formation and progression of descending thoracic aorta aneurysm (dTAA) in Rattus norvegicus. It is also used in research for neuromyelitis optica spectrum disorder (NMOSD) and dTAA [1] [2]. |
| molecular weight | N/A |
| CAS | 1535963-91-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |